Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials

MLA

Edoardo Mannucci, et al. “Cardiovascular Events and All-Cause Mortality in Patients with Type 2 Diabetes Treated with Dipeptidyl Peptidase-4 Inhibitors: An Extensive Meta-Analysis of Randomized Controlled Trials.” Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, vol. 31, no. 10, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aec8d51ff4b4d9061eed0a924bb7e9bb&authtype=sso&custid=ns315887.

APA

Edoardo Mannucci, Besmir Nreu, Chiara Montereggi, Benedetta Ragghianti, Marco Gallo, Andrea Giaccari, Matteo Monami, Riccardo Candido, Basilio Pintaudi, Giovanni Targher, Lina D. Monache, Maria L. Masini, Fulvia Mazzone, Gerardo Medea, Marina Trento, & Giuseppe Turchetti. (2021). Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, 31(10).

Chicago

Edoardo Mannucci, Besmir Nreu, Chiara Montereggi, Benedetta Ragghianti, Marco Gallo, Andrea Giaccari, Matteo Monami, et al. 2021. “Cardiovascular Events and All-Cause Mortality in Patients with Type 2 Diabetes Treated with Dipeptidyl Peptidase-4 Inhibitors: An Extensive Meta-Analysis of Randomized Controlled Trials.” Nutrition, Metabolism, and Cardiovascular Diseases : NMCD 31 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aec8d51ff4b4d9061eed0a924bb7e9bb&authtype=sso&custid=ns315887.